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Multi-OMICs analysis reveals metabolic and epigenetic changes associated with macrophage
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Macrophages (MФ) are an essential immune cell for defense and repair that travel to different tissues and
adapt based on local stimuli. A critical factor that may govern their polarization is the cross-talk between
metabolism and epigenetics. However, simultaneous measurements of metabolites, epigenetics, and
proteins (phenotype) has been a major technical challenge. To address this, we have developed a novel
triomics approach using mass spectrometry to comprehensively analyze metabolites, proteins, and
histone modifications, in a single sample. To demonstrate this technique, we investigated the metabolicepigenetic-phenotype axis following polarization of human blood-derived monocytes into either ‘proinflammatory M1’- or ‘anti-inflammatory M2-’ MФs. We report here a complex relationship between
arginine, tryptophan, glucose, and the citric acid cycle (TCA) metabolism, protein and histone posttranslational modifications, and human macrophage polarization that was previously not described.
Surprisingly, M1-MФs had globally reduced histone acetylation levels but high levels of acetylated amino
acids. This suggests acetyl-CoA was diverted, in part, towards acetylated amino acids. Consistent with this,
stable isotope tracing of glucose revealed reduced usage of acetyl-CoA for histone acetylation in M1-MФs.
Furthermore, isotope tracing also revealed MФs uncoupled glycolysis from the TCA cycle, as evidenced by
poor isotope enrichment of succinate. M2-MФs had high levels of kynurenine and serotonin which are
reported to have immune-suppressive effects. Kynurenine is upstream of de novo NAD+ metabolism which
is a necessary cofactor for Sirtuin-type histone deacetylases. Taken together, we demonstrate a complex
interplay between metabolism and epigenetics that may ultimately influence cell phenotype.

INTRODUCTION
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Macrophages (MФs) are essential phagocytes that mediate antimicrobial immunity. Mφ precursors,
monocytes, enter circulation and home to tissues where they differentiate into tissue-specific MФs that
express distinct markers. Multiple phenotypes have been described that perform site-specific functions
depending on the tissue environment (1-3). MФ differentiation and activation is a complex process
involving orchestrated signaling induced by cytokines, chemokines, and interactions with pathogenassociated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPS) (4).
Classically, activated MФs are ‘pro-inflammatory’ and referred to as M1-MФs, whereas alternatively
activated MФs are ‘anti-inflammatory’ and referred to as M2-MФs (5). M1-MФs can be induced by IFN-γ
from monocytes or resting MФs (M0-MФ), and M2-MФs are induced by IL-4, IL-10, and IL-13 (6). In
addition, multiple subsets of M2-MФs (M2a, M2b, and M2c) have also been described (7).
MФ polarization helps the immune system balance between the need to kill pathogens (M1-MФs) and to
perform repair following infection- and cytokine-related damage (M2-MФs) (8). Improper MФ polarization
can contribute to the pathophysiology of metabolic syndrome (9-11), infectious and autoimmune diseases
(12), asthma (13), and cancer (10,14). A better understanding of MФ polarization may allow us to develop
therapeutic strategies for tuning polarization.
Recent studies have shed some light on the interplay that exists between epigenetics and metabolism
that may be involved or even govern macrophage polarization (15,16). Previous studies, primarily using
mouse MФs, show a striking contrast between transcriptional and metabolic profiles between M1- and
M2-MФs (10,17-20). Typically iNOS is reported to be upregulated in M1-MФs resulting in arginine
catabolism to citrulline and nitric oxide, as well as produce reactive oxygen and nitrogen species (21). In
contrast M2-MФs, instead convert arginine into ornithine and urea using ARG1. Furthermore, M1-MФs
are characterized by enhanced glycolysis, an upregulated pentose phosphate pathway (PPP), and
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decreased oxidative phosphorylation (OxPhos) while M2-MФs are characterized by largely the opposite
(11,19,22). Furthermore, metabolites and nutrients in the microenvironment, including amino acids,
glucose, fatty acids, hormones, vitamins, and even oxygen, can further influence polarization (23-29).
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Histone epigenetic regulation can directly influence gene expression. Enzymes that add or remove these
modifiers to chromatin alter the physical accessibility of a set of genes and their promoters which can
directly influence gene expression (30,31). Both mathematical models and experimental observations
confirm acetylation changes occur depending upon the metabolic state. For example, a shift from low to
high glucose significantly affects histone acetylation levels, as do changes in acetate, hypoxia, or starvation
of certain amino acids (32-37). Histone acetylation and methylation are dependent upon their required
acetyltransferase and methyltransferase cofactors, acetyl-CoA and S-adenosylmethionine (SAM),
respectively. Acetyl-CoA is derived from pyruvate, the final product of glycolysis, as well as β-oxidation of
fatty acids. SAM is formed from methionine which can be imported or synthesized from homocysteine
and 5-methyltetrahydrofolate (5-methylTHF), which requires B12 and folate. Serine, or glucose derived
serine, is the source of carbon for 5-methylTHF. Consequently, epigenetic markers are a direct
consequence of multiple overlapping metabolic pathways that are differentially activated in polarized
macrophages.
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While epigenetic regulation is closely tied to the synthesis and availability of the necessary cofactors,
other factors produced by macrophages or in the microenvironment can further influence epigenetics. As
an example, vitamin B12 can be irreversibly bound to NO, which is upregulated in M1-MФs and inhibits de
novo methionine synthesis (38-41). In addition, others have demonstrated that itaconic acid (19,42,43)
can inhibit B12-dependent enzymes, and hypoxia can block intracellular uptake of B12 (44). In addition,
others have demonstrated an accumulation of 5-methylTHF in M2-MФs relative to M1-MФs (45).
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Previous approaches to measure metabolites, epigenetics, and protein expression (phenotype) have
required multiple techniques and a variety of instruments including one or more kinds of mass
spectrometers, western blot, qPCR, and other techniques. Each of these approaches are specialized and
thus can limit the study of the metabolic-epigenetic-phenotype axis. Herein, we describe a novel triomics
method to simultaneously analyze metabolites, histone modifications (epigenetics), and protein
expression (phenotype) using MФs polarized in vitro. Secondly, we describe a mass spectrometric method
to trace glucose incorporation into histone modifications (acetylation) that is based on our previous report
of tracing histone methylation derived from serine (46). Our work described herein provides an analytical
platform to study the complex crosstalk between metabolism, epigenetics, and cell plasticity. We
demonstrate this by applying our approach to study MФ polarization

RESULTS
Triomics-analysis of metabolites, proteins, and histone modifications
Figure 1 outlines our Triomics workflow where we extract proteins, metabolites, and histones from single
samples. After isolating each material, we can visualize differential expression with a volcano plot
comparing M1- and M2-MФs (Figure 2A). A total of 112 metabolites were identified and quantified. The
authenticity of metabolites was determined based on the accuracy of the precursor ions, which was set
at a threshold of 5.0 ppm. The majority were further validated by MS2 fragment ions that corresponded
to their chemical structures.
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A total of 15 modified histone peptides were quantified (Figure S1). Figure 2B shows a volcano plot
displaying the fold changes of modifications in M2-MФs versus M1-MФs with significance (p-value) of
change calculated from up to 8 measurements of a pooled sample containing 3 biological samples. The
data demonstrate that acetylation of histone H3 and H4 at all sites was consistently higher in M2-MФs
than in M1-MФs. Additionally, dipeptide acetylation of KS and KG, detected in our metabolomics assay,
was higher in M2-MФs than in M1-MФs. This suggests that these acetylated dipeptides could be
degradation products of acetylated proteins (Figure 2A).

of

As for methylated histone modifications, H3K4me3 was significantly higher in M1-MФs than M2-MФs.
Methylation at other sites including H3K9 (mono-, di-, and trimethylation), H3K27 trimethylation, H3K36
mono-methylation, K79 mono-methylation, H4K20 mono-, di, and trimethylation was either lower in M1MФs compared to M2-MФs or unchanged between them (Figure 2B & S1). This suggests that there are
significant alterations to the histone epigenetic code between M1- and M2-MФs, with histone acetylation
broadly being elevated in M2-MФs and methylation being downregulated or unchanged.

na

lP

re

-p

ro

A total of 2937 proteins were quantified with statistical significance (q-value ≤ 0.05). Figure 2C is a volcano
plot showing the relationship of log2 fold change of proteins differentially expressed in M2-MФs versus
M1-MФs and their statistical significance. 866 proteins were downregulated (blue) and 710 proteins were
upregulated (red) in M2-MФs versus M1-Mφs by >1.25 fold. Figure 2D illustrates a heatmap of protein
expression in M1- and M2-MФs compared to M0-MФs and between M1- and M2-MФs. Among the 10
most upregulated proteins, LGALS3/Galectin 3 was elevated in M1-MФs, consistent with our previous
RNA-seq analysis (47). LGALS3 is associated with autophagy-dependent antibacterial activity (48). Also,
consistent with our transcriptome analysis, RelA was significantly upregulated in M1-MФs whereas SIRT2
was upregulated in M2-MФs. SIRT2 is known to regulate the expression of RelA deacetylation, thereby
modulating its function (49).
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We then took the differentially expressed proteins for pathway enrichment analysis, using g:Profiler and
Cytoscape with EnrichmentMap for visualization (50). IFN-γ signaling, response to type I interferon, NADHrespiratory chain complex 1, MHC-I dependent antigen processing, glycolysis, and ROS/NOS in phagocytes
were among the enriched pathways in M1-MФs (Figure 3A). In comparison, antigen presentation MHC
class II, tricarboxylic acid (TCA) cycle, and oxidative phosphorylation (oxPhos) were enriched in M2-MФs
(Figure 3B).
Arginine metabolism and arginine methylation
iNOS is a hallmark in activated M1-MФ's. iNOS consumes arginine and metabolizes it to citrulline,
producing nitric oxide (NO). On the other hand, M2-MФs are frequently defined by the high expression of
ARG1, which instead metabolizes arginine into ornithine and urea. While ornithine was elevated in M2MФs, we did not see higher citrulline in M1-MФs as expected. Instead, both citrulline and ornithine were
significantly higher in M2-MФs (Figure 4A-B). Despite this, we found evidence of NO oxidation in M1-MФs.
We detected the Nitric oxide synthase intermediate, NG-hydroxy-arginine (NOHA), although it was not
significantly different between different MФs. However, NO can also react with tyrosine to form
nitrotyrosine which was also found significantly higher in M1- compared to M2-MФs (Figure 4A). The high
levels of citrulline in M2-MФs, rather than in the M1-MФs, are best explained by ornithine conversion into
citrulline by ornithine transcarbamylase (OTC). Ornithine can then be metabolized to pyrroline 5carboxylate (P5C), which can be further metabolized into proline or glutamate (Figure 4A-B). Overall, we
find that M2-MФs elevate ornithine and citrulline levels likely due to conversion of arginine to ornithine
and ornithine to citrulline, by ARG1 and OTC, respectively.
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Alternatively, arginine can instead be metabolized to creatine or agmatine. Agmatine was higher in M2MФs. Agmatine is a precursor of polyamines which can suppress iNOS expression after inflammation,
potentially playing an anti-inflammatory role (51,52). Alternatively, arginine can be combined with glycine
to produce ornithine and guanidinoacetate. Guanidinoacetate can then be converted to creatine following
methylation using SAM. However, we found creatine levels in M2-MФs were not statistically different
while absolute levels of agmatine were 10-20x higher than creatine. This suggests arginine is preferentially
converted to agmatine.
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Additionally, arginine residues in proteins can be methylated by arginine methyltransferases (PRMTs).
These proteins can be catabolized to produce mono- and dimethylated arginine (Rme1 & Rme2) as well
as dipeptides, GRme2 and Rme2G. These were all higher in M1- compared to M2-MФs (Figure 4C). Based
on mass spectrometry, arginine dimethylation was predominately asymmetric because the MH+-45 ion
(loss of dimethylamine) was detected, but the symmetric demethylation signature MH+-31 ion (loss of
methylamine) was not (53). Interestingly mono-methylated arginine, also known as N-mono-methyl-Larginine (L-NMMA), and asymmetric dimethylated arginine (ADMA) are known to modulate NO
production by competing with arginine for NOS binding (54).
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Tryptophan metabolism
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In contrast, monomethylated arginine dipeptides, Rme1G and GRme1, were significantly lower in M1MФs. We were unable to detect PRMT1, which is the major asymmetric arginine dimethyltransferase
(55,56). Protein Arginine Methyltransferase 5 (PRMT5) was the only arginine methyltransferase among
PRMT1-8 detected by proteomics and was upregulated in M2-MФs. PRMT5 can methylate histone H4R3
in the mono- and symmetric dimethylation form to repress gene expression. In addition, previous studies
show that PRMT5 can methylate RelA-R30 to regulate the transcription of a subset of TNF-α-induced proinflammatory genes, including CXCL10 (57,58). These intriguing data from our metabolic analysis warrant
additional studies on the role of arginine metabolism and methylation, especially in the context of histone
arginine methylation during MФ polarization and activation.
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Tryptophan can be metabolized by tryptophan hydroxylase to form 5-hydroxyl-tryptophan (5-HO-Trp) and
later form serotonin. Alternatively, indolamine-2,3-dioxygenase 1 (IDO1) can metabolize tryptophan to
form N-formyl-Kynurenine and ultimately, Kynurenine. IDO1 has antibacterial and immunosuppressive
functions (59). Notably, its product, kynurenine, can mediate antimicrobial functions (60). We found that
serotonin concentration was several-fold lower in M0- and M1-MФs than in M2-MФ (Figure 5A). This
could be due to the inhibition of tryptophan hydroxylase (TPH) by NO (Figure 5B) (61). A higher level of
serotonin in M2-MФ is consistent with earlier reports that serotonin has anti-inflammatory effects and
suppresses the release of TNF-α and IL-1β in immune cells and IFN-γ-induced phagocytosis at high
concentrations (62-64).
Kynurenine was dramatically increased in M2-MФs compared to M0- and M1-MФs (Figure 5A).
Kynurenine is known to act on the aryl hydrocarbon receptor, which can dampen the immune system
response (65). Kynurenine can be further metabolized into downstream products, including NAD+, a
critical energy metabolite for redox reactions, and it serves as the substrate for Sirtuin histone-modifying
enzymes. We also detected other products of tryptophan metabolism, including picolinic acid, which was
only moderately increased in M1-MФs (Figure 5A-B). We quantified three proteins in the tryptophan
metabolic pathway, including kynurenine 3-monooxygenase (KMO), kynureninase (KYNU), and
quinolinate phosphoribosyltransferase (QPRT) (Figure 5C). KMO expression was decreased by 25% in M1MФs compared to M2-MФs; KYNU expression was comparable, but QPRT expression increased fourfold
in M1-MФs compared to M2-MФs (Figure 5C).
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De novo NAD+ biosynthesis requires QPRT which was decreased in M2-MФs. However, M2-MФs have
higher levels of kynurenine and serotonin but lower levels of QPRT protein. This indicates the complex
regulation of tryptophan metabolism at the proteomic and metabolomic level. High levels of kynurenine
in M2-MФs might suggest increased NAD+ production as there may be increased utilization of the de novo
synthesis pathway. However, M1-MФs may simply have a higher flux through the de novo NAD+ pathway
and more readily produce NAD+ as an end product. M2-MФs, on the other hand, may accumulate these
precursors which are believed to dampen immune responses (65), at the cost of producing NAD+. Our
initial study here cannot determine which possibility is correct although the latter explanation would be
consistent with the elevated histone acetylation in M2-MФs as a lack of NAD+ would provent Sirtuins from
deacetylating histones. Further studies directly measuring NAD+ as well as using isotope tracing studies
with tryptophan would be required to fully understand the utilization of this pathway.
Central carbon metabolism and histone acetylation
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Central carbon metabolism refers to the metabolic pathways, including glycolysis, the TCA cycle, and the
electron respiratory chain. We successfully quantified nearly all catalytic enzymes in glycolysis using
proteomics (Figure 6A). The following glycolytic enzymes were elevated in M1-MФs:
phosphoglucomutase 1 (PGM1), triosephosphate isomerase 1 (TPI1), fructose-bisphosphatase 1/2 (FBP1
and FBP2), fructose-bisphosphate aldolase A (ALDOA), and enolase 2 (ENO2). Alternatively, the following
glycolytic enzymes were elevated in M2-MФs: Hexokinase 1/2/3 (HK1, HK2, and HK3), liver typephosphofructokinase (PFKL), glucose-6-phosphate isomerase (GPI), pyruvate kinase 2 (PKM2),
glyceraldehyde-3-phosphate
dehydrogenase,
and
spermatogenic
(GAPDHS).
Levels
of
phosphoglucomutase 2 (PGM2), enolase 1 (ENO1), and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) were comparable between the two states. Figure 6B displays altered expression profiles of
proteins in the TCA cycle and its coupled pyruvate and aspartate/glutamate pathways.
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Except for citrate synthase (CS) and malate dehydrogenase 2 (MDH2), which were not differentially
expressed, all TCA cycle enzymes detected were upregulated in M2-MФs. The major enzymes involved in
pyruvate metabolism, pyruvate kinase M2 (PKM2), and lactate dehydrogenase A/B (LDHA and LDHB) were
upregulated in M2-MФs, except lactate dehydrogenase D (LDHD) which was upregulated in M1-MФs.
These results are consistent with prior reports of elevated TCA pathway in M2-MФs.
While glucose is the typical source of carbons for the TCA pathways glutamate can also be used to fuel
the TCA cycle. In M1-MФs we found increased levels of glutamic-oxaloacetic transaminase 1 (GOT1),
glutamate dehydrogenase 1(GLUD1), glutamate-ammonia ligase (GLUL), glutaminase (GLS), and solute
carrier family 1 member 3 (SLC1A3). These results suggest that M1-MФs may upregulate
glutamine/glutamate incorporation into the TCA cycle rather than glucose.
Consistent with the elevated TCA enzymes in M2-MФs, we generally observed a corresponding increase
in the enzymes involved in oxidative phosphorylation. Figure 6C displays altered expression of
mitochondrial respiration chain proteins. Mitochondrial electron transport chain complex I (ETC) proteins
were unchanged, except for NADH:Ubiquinone Oxidoreductase Complex Assembly Factor 4 (NDUFAF4)
which was upregulated in M2-MФs. Complex II enzymes, Succinate dehydrogenase A and B were
comparable between M1- and M2-MФs. Five members of complex III were upregulated in M2-MФs,
including cytochrome B (CYB)-A, 5A, 5B, 5R1, and 5R3. In contrast, CYBB was solely upregulated in M1MФs. Elevated CYBB, also called NOX2, is consistent with reports that it is a primary component of the
microbicidal phagocyte oxidase system and generates reactive oxygen species in M1-MФs (66). The
following Cytochrome C oxidases (COX) of complex IV were upregulated in M2-MФs: COX2 (MT-CO2)
fragment, COX5B, COX15, COA3 (COX assembly factor 3), OXA1L (COX assembly 1-like), and TACO1
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(translational activator of COX1). On the other hand, COX5A, COX6C, COX7C, and COA5 (COX assembly
factor 5) were upregulated in M1-MФs. ATP synthases are also differentially expressed: ATP5A/B/C/D/L
were upregulated in M2-MФs, whereas ATP5E/G3/I/J were upregulated in M1-MФs.
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All metabolites related to the TCA cycle and its coupled pyruvate and aspartate/glutamate pathways were
measured using the O-Benzhylhydroxylamine (O-BHA) derivatization-LC-MS/MS method. Pyruvate (Pyr)
and lactate (Lac) concentrations were significantly higher in M1-MФs. We also found decreased citrate
and α-ketoglutarate (α-KG) in M1-MФs. However, citrate/isocitrate isoforms were not fully resolved by
our LC/MS method. These findings are consistent with previous reports that the TCA cycle is blocked
before α-KG formation, by inhibition of either IDH or aconitase 2 (ACO2) via NO inhibition (19,67). No
differences in succinate or malate concentrations were found in M1- and M2-MФs (Figure S2). However,
Oxaloacetate (OAA) was elevated in M1-MФs (Figure 2A), but OAA can be derived from aspartate or
glutamate (68). Both Aspartate and Glutamate were significantly higher in M2-MФs compared to M1-MФs
(Figure 6D-E). This may indicate that they accumulate in M2-MФs but are used in M1-MФs to form OAA
for entry into the TCA cycle.
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Acetylated aspartic acid (NAA) and acetylated glutamate (NAG) were elevated in M1- relative to M2-MФs
(Figure 2A and 6D-E). The concentration of NAA was ten times that of NAG, suggesting that NAA is the
major pool of acetyl groups. The measured NAA concentration (~0.4 nmol/mg protein in M1-MФs and
~0.2 nmol/mg protein in M0- and M2-MФs) was comparable to the concentrations measured in
immortalized brown adipocytes (0.1 nmol/mg protein) (69-72). Surprisingly, N-acetyl-ornithine (NAO) was
also abundant (Figure S3), and its concentration in M1-MΦs was about four times that of M2-MΦs and
two times that of M0-MΦs (Figure 6D-E). NAO is the metabolic product of NAG (73). We propose that
higher levels of NAA, NAG, and NAO in M1-MΦs may function as acetyl-CoA trap that could result in the
observed decreases in histone acetylation (Figure 2A-B).
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Tracking acetyl groups into histone acetylation
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To better understand how glucose metabolism affects histone acetylation, we performed isotope tracing
using uniformly labeled 13C6-glucose. Isotope enrichment of pyruvate and lactate was higher in M1-MФs
than M0-MФs, confirming the upregulation of glycolysis by IFN-γ (Figure 7A). However, levels of pyruvate
and lactate were higher in M2-MФ. Unexpectedly the total isotope enrichment of pyruvate was only 12% while lactate was 10-15%. This would appear to indicate that pyruvate is being diverted to either
lactate or acetyl-CoA. However, we see a similar 1-2% enrichment of succinate suggesting acetyl-CoA is
largely not being incorporated into the TCA cycle. Consistent with this, isotope labeled glucose
incorporation into H3K18/23 acetylation is enriched by 20-25% which indicated that production of acetylCoA is not blocked but rather is diverted to histone acetylation rather than into the TCA cycle (Figure 7B).
Decreased enrichment of succinate M+2 isotopologue (13C2) (Figure 7A) confirms TCA cycle impairment at
the formation of α-KG, which is also indicated by proteomics (Figures 6B). 13C2-acetyl incorporation from
glucose to histones was measured as illustrated by Figure S4. Enrichment is higher in M1- and further
increased in M2-MФs, compared to M0-MФs, although the differences are relatively modest (Figure 7B).
These results are consistent with reduced global histone acetylation in M1-MФs compared to M2-MФs in
non-isotope tracing experiments (Figure 2B).
To examine the effects of hypoxia on histone modifications and isotope incorporation, MФs were cultured
otherwise identically but under hypoxic conditions (2% O2). Levels of H3K18/23Ac isotope enrichment
were decreased in M0 and M2- MФs relative to normoxia. Consequently, the relative enrichment of this
7

modification is higher in M1-MФs than either M0 or M2 MФs under hypoxia. This observation is consistent
with a previous report indicating that hypoxia suppresses metabolism through the TCA cycle by transactivating the gene encoding pyruvate dehydrogenase kinase 1 (PDK1). PDK1 then inactivates the
Pyruvate Dehydrogenase Complex (PDH) which results in decreased acetyl-CoA formation from glucose
metabolism (74). Furthermore, one-carbon metabolism appeared to be inhibited in M1-MФs as there was
reduced methyl transfer from serine to histones. Hypoxia further enhanced this effect (Figure S5).

DISCUSSION
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We have developed an innovative triomics method to understand the crosstalk between metabolism and
histone modifications during IFN-γ and IL-4-mediated polarization of human MФs. From acetone extracts
of cell lysate, we were able to quantify hundreds of metabolites containing primary amines or carboxylic
acids using dansylation and O-benzylhydroxylamine (O-BHA) derivatization, respectively. The
concentrations of the 20 amino acids, modified amino acids/dipeptides, such as methylated lysine and
arginine, acetylated lysine and ornithine, arginine and glutamate metabolism, and tryptophan
metabolism, were successfully quantified by dansylation derivatization followed by LC-MS/MS analysis.
Concentrations of TCA cycle intermediates were measured by O-BHA derivatization followed by LCMS/MS analysis. We compared their relative concentration levels in M0-, M1-, and M2-MФs.
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In M1-MФs we saw increased levels of nitrotyrosine supporting their role in producing reactive nitrogen
species to combat pathogens. Consistent with the ‘anti-inflammatory’ role of M2-MФs, tryptophan and
arginine pathways revealed elevated levels of agmatine, serotonin, and kynurenine which are all believed
to play some anti-inflammatory role. Additionally, glutathione detoxification was significantly
upregulated, and ROS formation is downregulated in M2-MФs (Figure S6A). A corresponding decrease of
4-HNE (Figure 2A), a marker as lipid peroxidation, as well as oxidized threonine (AAAS), and lysine (AKBA)
was observed (Figure S6B-C). However, based on our results at the protein and metabolite level, previous
reports that suggest a ‘glycolytic’ M1 subtype and an ‘Oxphos’ M2-subtype generalization may be just
that, a generalization, and the dynamics of those pathways, and their intersection with MФ polarization,
may be more complex than previously appreciated.
Interestingly, in all MФ subtypes studied herein, stable-isotope tracing with glucose suggested that very
little glucose made its way into the TCA cycle (Figure 7A). While the proteomic data suggested that M2MФs may upregulate Oxphos, it appears that MФs overall do not utilize glucose molecules in the TCA
cycle. It is possible that the enrichment of succinate is poor, not because the TCA cycle is dysfunctional,
but rather that other sources of carbons, such as glutamate, are being preferentially used.
LC-MS/MS analysis demonstrated that histone acetylation was significantly lower in M1-MФs than M2MФs (Figure 2B). Our metabolomics data identified an accumulation of N-acetyl-aspartic acid (NAA), Nacetyl-glutamate (NAG), and the NAG metabolic product N-acetylornithine (NAO) in M1-MФs which may
explain the decreased levels of histone acetylation relative to M2-MФs. Although differential expression
of histone acetyltransferases and deacetylases cannot be ruled out, lower acetyl-CoA production from
glycolysis and blocked acetyl release from NAA, NAG, and NAO could also explain the epigenetic
differences in polarized MФs.
Importantly, de novo synthesis of NAD+ through tryptophan metabolism was significantly upregulated in
M1-MФs, as evidenced by elevated levels of nicotinic acid and significant overexpression of QPRT (Figure
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5). We predict that the production of NAD+ by oxidation of NADH via mitochondrial respiratory complex I
is enhanced in M1-MФs, because most complex I proteins were upregulated (Figure 6C). Elevated NAD+
from tryptophan metabolism as well as NADH oxidation may, in turn, enhance the activity of sirtuin-type
histone deacetylases, thereby reducing histone acetylation. Our metabolomic approach did not measure
NAD+ levels and only provides a snapshot of tryptophan metabolism. Future studies should be done to
investigate the mechanism by which we identified higher levels of kynurenine in M2-MФs, but higher
levels of downstream metabolites, closer towards NAD+ synthesis, in M1-MФs. Tryptophan metabolism
may be a major contributor to the respective roles of M1 and M2-MФs in immune activation.
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Because acetyl-CoA can also be produced from fatty acid β-oxidation, we sought to determine whether
fatty acid β-oxidation occurs differentially in M0-, M1-, and M2-MФs (Figure S6). Our data suggest that
there are no significant differences in fatty acid β-oxidation among the three types of MФs.
Concentrations of middle to long-chain fatty acids, including hexanoic acid, palmitic acid, and palmitoleic
acid, were significantly lower in M1-MФs. If these were degraded by β-oxidation to short-chain fatty acids,
we should have detected considerably higher concentrations of acetic and butyric acids. However, this
was not found (Figure S6B-C). Middle to long-chain fatty acids are likely consumed to synthesize very long
chain fatty acids due to upregulation of ELOV1 (Figure S6A).
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Methylated arginine derived from protein and or histone degradation, and their specific
methyltransferases, may regulate MФ polarization. Dimethylated arginine-glycine (RG/GR) peptides were
highly abundant and present in significantly higher quantities in M1- relative to M2-MФs. Although further
confirmation is needed, the data suggests RG/GR-domain-containing proteins such as H4-R3 and RelA
(R30), are hypermethylated. Perhaps most importantly, L-NMMA and ADMA are also known to modulate
NO production by competing for the arginine binding site of NOS. This creates a potential intersection of
arginine metabolism, protein post-translational methylation which is SAM/one-carbon metabolism
dependent, protein degradation, and the modulation of NO production.

Jo

Experimental procedures

M1- and M2-MФ cell culture, differentiation, isotope tracing, and hypoxia
Human peripheral blood-derived buffy coat of HIV negative and MTB negative healthy donors (male and
females, deidentified) were purchased from the Gulf Coast Regional Blood Center/Bank in Houston (1400
La Concha Ln, Houston, TX 77054), which is exempt from IRB regulations of Houston Methodist Research
Institute. Blood from about 10 donors was used in this study. All blood samples were processed per
approved IRB (HSCA00000993) protocols of the Houston Methodist Research Institute. Procedures and
phenotype/purity determination of PBMC-derived and -differentiated macrophages have been previously
described (29). Briefly, CD14+ magnetic bead (Miltenyi Inc., USA)-purified monocytes from PBMCs were
grown in Iscove's medium (IMDM) with 10% FBS and 10 ng/mL GM-CSF at 4x106 per well in six-well tissue
plates for 6 days and then rested for 24 h in GM-CSF-free medium. Cells were differentiated using IFN-γ
(10 ng/mL) or IL-4 (10 ng/mL) in GM-CSF-free medium for 48 h to obtain M1- and M2-MΦs, respectively.
M0-MФs were not treated with cytokines. For isotope tracing experiments, M0-, M1-, and M2-MΦs were
washed once with PBS and then incubated in RPMI-1460 medium with stable isotope-labeled 2 g/L Dglucose (U-13C6, 99%, Cambridge, Ca#: CLM-1396-1) and 200 µM L-serine (2,3,3-D3,98%, Cambridge, Ca#:
DLM-582-0.5) for an additional two and three days, respectively. IFN-γ (10 ng/mL) or IL-4 (10 ng/mL) were
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added again for M1- and M2-MΦs. Separated sets of M0-, M1-, and M2-MΦs were cultured and treated
simultaneously under hypoxic conditions (2% O2).
Triomics approach
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Triomics refers to 'metabolomics, proteomics, and OMICs of histone modifications.' We integrated these
three OMICs seamlessly in a one-sample preparation followed by an analysis of metabolites, histone
modifications, and proteins on the QExactive mass spectrometer (Figure 1). Briefly, cell pellets of M0-,
M1-, and M2-MФs were lysed using radioimmunoprecipitation assay (RIPA) buffer (ThermoFisher
Scientific, Cat#:89901) supplemented with 1% Nonidet P40, PMSF (0.2 mM), and Roche complete
protease inhibitor cocktail (ThermoFisher Scientific, Cat#: 50-100-3301, one tablet per 10 mL lysis buffer).
The protein concentrations were measured by Bicinchoninic Acid Assay (BCA). An aliquot (~100 µL) of
lysate containing 100 µg proteins was immersed in 500 µL of precooled (-20°C) acetone overnight. After
centrifugation, metabolites in the supernatant were submitted for metabolomics analysis, and the
proteins in the precipitates were used for the analysis of histone modifications and differential proteins
expression.
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Analysis of primary amines including amino acids by dansylation derivatization followed by nanoLCMS/MS analysis
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Primary amine compounds, including amino acids, were derivatized by dansylation before analysis by
nano-LC/MS based on a method (75), (76) and adapted to our nanoLC-QExactive systems. Briefly, 100 µL
acetone extraction was mixed with 10 µL internal standards containing 0.1 mM 13C2, 2,2-2H2, 15N-Glycine
(Cambridge isotope Lab., Cat#: CDNLM-6799-0.25), 0.1 mM 13C3, 2H3, 15N-Serine (Cambridge isotope Lab.,
Cat#: CDNLM-6813-0.25) and 0.1 mM Methyl-D3-Methionine (Cambridge isotope Lab., Cat#: DLM-431-1),
vacuum-dried, and then 30 µL of 0.5M Na2CO3/NaHCO3 and 100 µL of dansyl chloride (4 mg dissolved in 1
mL acetone) was added and incubated at 55°C for 1 h. After drying under vacuum, dansylated metabolites
were dissolved in 50 µL 88% formic acid and 50 µL 1% formic acid. A 20 µL-aliquot was desalted by C18
desalting columns. After removal of acetonitrile which was used to elute the dansylated compounds,
eluates were dissolved in 50 µL 40% methanol in 1% formic acid. This solution with further diluted 10x
with 1% formic acid. 2 µl of this solution was injected each time through the autosampler and analyzed
by nanoLC-MS/MS on the QExactive benchtop orbitrap mass spectrometer. The HPLC column was made
in-house by packing Magic C18-AQ (100 Ǻ, 3 µm, Bruker, Cat#: PM3/61100/00) package material into 20
cm (length) x 360 µm (outer diameter) x75 µm (internal diameter) capillary with PicoTip emitter (New
Objective, Cat#: PF360-75-15-N-5) under high pressure. Using this method, amino acids, serine, glycine,
and methionine were accurately measured using their stable-isotope labeled compounds as internal
standards, and concentrations of other compounds were estimated by mass spectrometry signal
normalization against that of either serine in the low retention time zone or glycine in the high retention
time zone.
Analysis of carbonyl-containing compounds including TCA intermediates by O-BHA derivatization
followed by nanoLC-MS/MS analysis
A previously reported method was adapted (77). Acetone extracts (200 µL), with added 10 µL mixture of
internal standards containing 0.1 mM each of sodium D3-pyruvate (Cambridge isotope Lab., Cat#: DLM6068-0), sodium 13C3-L-lactate (Cambridge isotope Lab., Cat#: CLM-1579-N-0.1MG), 1,5,6-13C3-citric acid
(Cambridge isotope Lab., Cat#: CLM-9876-0.1MG), 1,2,3,4-13C4-α-ketoglutaric acid disodium salt
(Cambridge isotope Lab., Cat#: CLM-4442-0.1MG), 13C4-succinic acid (Cambridge isotope Lab., Cat#: CLM1571-0.1MG), 13C4-fumaric acid (Cambridge isotope Lab., Cat#: CLM-1529-0.1MG), 13C4-L-malic acid
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(Cambridge isotope Lab., Cat#: CLM-8065-0.1MG), were completely dried under vacuum. In the dried
vials, 50 µL of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC), 100 µL of O-benzylhydroxylamine
(O-BHA) in pyridine buffer (preparation (200 mL): 15 mL of pyridine (99.8%, Sigma) + 10 mL HCl (12 N) and
175 mL H2O) were added sequentially and then incubated at 30°C for 1 h. After derivatization, metabolites
were extracted by 2 x 300 µL ethyl ester. After vacuum drying, 200 µL of 40% methanol was added to
dissolve the metabolites. The solution was further diluted 10x with 1% formic acid and submitted for
nanoLC-MS/MS analysis on the QExactive. Using this method, carboxylic acids were analyzed. The
concentrations of TCA intermediates were accurately measured using their stable isotope-labeled
compounds as internal standards, whereas others were estimated by mass spectrometric signal
normalization against malate.
Analysis of histone modifications and the transferring of acetyl-groups from metabolites to histones

na

Analysis of protein expression
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An aliquot of cell lysate containing 20 µg of total proteins was mixed with 1 µg of SILAC-produced heavy
arginine (13C615N4, aka, 10R) histones (purity > 99%) before being loaded onto SDS-PAGE gel for
electrophoresis separation. Gel bands covering molecular weights from 9 to 20 KDa containing histones
were cut for in-gel digestion with trypsin. Quantification of histone modifications was carried out by
parallel-reaction-monitoring (PRM) on the QExactive instrument using a previously reported inclusion list
(78,79). The ratios of MS peak areas of modified peptides over histone peptides without modifications
were calculated as the modification percentages used for comparison among M0-, M1-, and M2-MФ
samples. For monitoring methyl- transfer from 3,3,2-2H-serine or acetyl- from 13C6-glucose to histones,
except that no 10R-histones were added as internal standards. In this case, relative ratios of the ion
intensities of isotope-labeled 13C2-acetyl-lysine peaks over those of unlabeled peaks were calculated as
the isotope incorporation (or transfer) rates.

Jo

ur

Cell lysates of each sample containing 50 µg of proteins were reduced by adding 200 µM TCEP (tris(2carboxyethyl) phosphine) and incubating at 55°C for 1 h, followed by carbamidomethylation of cysteines
by adding 375 mM iodoacetamide and incubating the mixture in the dark for 30 minutes. Proteins were
precipitated by adding six volumes of precooled acetone and freezing at -20°C overnight and then pelleted
at 13,000 rpm for 10 min at 4°C. The protein pellets were then dissolved in 100 mM triethylammonium
bicarbonate (TEB) buffer followed by digestion with trypsin/Lyc-C (ThermoFisher Scientific, Cat#: A40007)
at a protein/enzyme ratio of 25:1. A tandem mass tag (TMT) labeling kit (TMTsixplex (TMT6))
(ThermoFisher Scientific, Cat#: 90064) was used to label the peptides according to manufacturer
instructions. All of the indicated chemicals and solutions were included in this kit unless otherwise
specified. M0-, M1-, and M2-MФ samples were labeled with TMT6 -126 and TMT6-127, TMT6 -128 and
TMT6-129, and TMT-130 and TMT-131, respectively. After labeling and quenching, the six samples were
desalted by Pierce graphite spin columns (ThermoFisher Scientific, Cat#: 88302) and then mixed. The
peptide mixture was fractionated into eight fractions with the Pierce High pH Reversed-Phase Peptide
Fractionation Kit (ThermoFisher Scientific, Cat#: 84868) and dried by vacuum centrifugation. Each fraction
was resuspended in 25 µL 1% formic acid and analyzed by nanoLC-MS/MS on the QExactive. The same
column used for metabolite analysis was used for peptide separation. Reversed-phase liquid
chromatography was run for 230 min (solvent A, 0.1% formic acid in water; solvent B, 0.1% formic acid in
acetonitrile). A gradient of 5%-45% of solvent B was used for peptide separation. The QExactive was set
to acquire data at a resolution of 35,000 in full scan mode and 17,500 in MS/MS mode. The top 15 most
intense ions in each MS survey scan were automatically selected for MS/MS. The LC- and MS-running
conditions (settings) were very similar for metabolites and peptides.
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Data analysis and statistical analysis
Each sample was a pool of cell pellets from three wells of a six-well plate (3x4x106 cells). At least 8
injections of LC-MS/MS were performed for every sample analyzed. Metabolomics data acquired from
QExactive instrument were processed by Xcalibur. Metabolite peak areas were integrated after manually
inputting the calculated metabolites of interest. Less than 5 ppm between calculated mass and measured
mass was considered an authentic identification; however, in most cases, identification was further
verified by fragmentation patterns consistent with the molecule's chemical structure. A two-tailed
Student's t-test was used to test for the significance of metabolic changes between M1- and M2-MФ for
the volcano plot visualization. Otherwise for all bar graphs shown a one-way ANOVA was used with
Dunnett’s test for multiple comparisons to the M1-MФs with GraphPad PRISM. P-values < 0.03 are
denoted *, <0.002 **, < 0.0002 ***, < 0.0001 ****.
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Histone modifications were evaluated by the percentage (or ratio) of the peak area of a modified peptide
over a peptide free of modifications which were normalized to the percentage (or proportion) of the same
pair of peptides with stable isotope labeling at arginine (79). Two-tailed Student's t-Test of the Excelimbedded T.TEST function was used to test for the significance of modification changes between M1- and
M2-Mɸ.
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Proteins were identified with the Proteome Discoverer (PD) 2.2 platform (version 2.2.0.388, Thermo
Fisher Scientific) using the SEQUEST HT search engine that employs the nr_human_062321validated.fasta
database with 420779 protein sequence entries (downloaded on June 23, 2021). SEQUEST HT parameters
were specified as trypsin enzyme, three missed cleavages allowed, minimum peptide length of four,
precursor mass tolerance of 10 ppm, and a fragment mass tolerance of 0.02 Da. Oxidation of methionine,
acetylation at N-terminal, TMT at lysine, and deamination of asparagine were set as variable
modifications. Carbamidomethylation of cysteine and TMT at peptide N-termini was set as a fixed
modification. Peptides were filtered for a maximum false discovery rate of 1% (strict). Protein
quantification was also through PD 2.2 using the reporter ion ratios of TMT for each set. Reporter ions
were quantified from MS2 scans using an integration tolerance of 0.04 Da with the most confi dent
centroid setting. At least one unique peptide with a posterior error probability of <0.05 was accepted
for quantification, and proteins were grouped. Differential expression between M1- and M2-Mɸs was
done using significance analysis of microarrays with permutation-based multiple test correction in the
Perseus software (1.6.12.0) (80). The false detection rate was set to 0.01 (1%), and s0 set to 0.32 (~1.25x
fold change cutoff).
Protein interaction networks were built upon the list of proteins in gene names identified by proteomics
whose expressions had significant changes using the STRING web-based software. Output coordinates
were revisualized by Cytoscape with nodes colored from blue (negative Log2 fold change) to red (positive
Log2 fold change) based on protein quantification data. Pathways corresponding to a group of proteins
selected from proteomics data meeting defined criteria were identified by g:Profiler and visualized by
Cytoscape with EnrichmentMap APP (50).
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Figure 1. Workflow for triomics for analysis of metabolites, histone modifications (epigenetics), and
protein expression (phenotype).
Cell lysates of M0-, M1- and M2-macrophages (MФs) are immersed into acetone for extraction of
metabolites (supernatants) and proteins (precipitates). A portion of metabolite extract is
derivatized by dansylation to analyze primary amines and another portion is derivatized by O-BHA
to analyze carboxyl acids by nanoLC-MS/MS. Proteins are resolved by SDS-PAGE and gel bands
containing histones (MW < 20K) are cut for in-gel digestion and histone modifications are analyzed
by nanoLC-MS/MS using Parallel Reaction Monitoring. Proteins are in-solution digested by
trypsin/Lys-C. Peptides are labeled by TMT6plex. TMT6-labeled peptides are analyzed by nanoLCMS/MS to determine protein expression changed and perturbated protein pathways.
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Figure 2. Alteration of metabolites, histone acetylation and methylation, and protein expression in M1and M2-Mɸs.
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A. Volcano plot of the fold change in metabolites of M1- versus M2-MФs. The x-axis is the log2 of
fold changes and the y-axis is the significance of the change of each corresponding metabolite
with log10 (p-value) calculated by Student's two-way t-test from at least eight consecutive LCMS/MS runs. Two separate sample preparation and analysis, and in each preparation of cells from
three wells of six-well plates were combined.
B. Volcano plot of the fold change in histone acetylation and methylation in M1- versus M2-MФs.
The plot also includes methylation of arginine, lysine amino acids or two-amino-acid peptides,
acetylation of aspartate (NAA), glutamate (NAG), and ornithine (NAO). Data were acquired from
the same sample preparation as in A. Biological and technical replicates, and statistical analyses
are also the same as in A.
C. Volcano plot of the fold change of proteins in M1- versus M2-MФs. Protein quantification was
performed with one of the two sample preparations and one additional technical replicate was
applied by labeling each sample (M0-, M1-, and M2-MФs) with two TMT tags. Significance of fold
changes was tested by microarrays permutation with Perseus software based on FDR set to 0.01
(1%) and s0 set to 0.32 (~1.25x fold change cutoff).
D. Heatmap analysis of up and downregulated proteins in M2-MФ compared to M1-MФ and both
relative to M0-MФ.
Figure 3. Enriched protein pathways in M1-Mɸ and M2-Mɸ.
A. Enriched pathways built from upregulated proteins in M1-MФs.
B. Enriched pathways built from upregulated proteins in M2-MФs.
Figure 4. Arginine metabolism and methylation in M1-Mɸ vs.M2-Mɸ
A. Concentrations of arginine pathway metabolites in M0-, M1-, and M2-MФs measured by LC-MS.
Concentrations were calculated by normalizing the signal intensity relative to an internal standard
of known concentration, 3,3,2-2H-serine.
B. Arginine pathway showing metabolites framed in red or green colors indicating an increase in
either M1-MФ or M2-MФ. PMRT: Protein Arginine Methyltransferase, ADC: Arginine
decarboxylase, AGAT: Arginine:Glycine Amidinotransferase, ASL: Argininosuccinate Lyase, ASS:
Argininosuccinate Synthase, OAT: Ornithine Aminotransferase, OTC: Ornithine Transcarbamylase.
C. Heat map showing differential levels of arginine methylation in M0-, M1-, and M2-MФs.
Figure 5. Tryptophan metabolism in M1-Mɸ vs.M2-Mɸs.

19

A. Concentrations of tryptophan pathway metabolites in M0-, M1-, and M2-MФs measured by LCMS. Concentrations were calculated by normalizing the signals of targeting compounds against
the signal of 10 µL of 0.1 mM 13C2, 2,2-2H2, 15N-Glycine spiked in 200 µL of acetone extracts.
B. Tryptophan pathway showing metabolites framed in red or green colors indicating an increase in
either M1-MФs or M2. IDO: indoleamine 2,3-dioxygenase, TPH: tryptophan hydroxylase, KMO:
kynurenine
3-monooxygenase,
KYNU:
kynureninase,
QPRT:
quinolinate
phosphoribosyltransferase.
C. Heat map of the expressions of proteins identified in the tryptophan pathway.
Figure 6. Protein and metabolite alteration in glycolysis, TCA cycle, mitochondria respiration, and
aspartate/glutamate to pyruvate shunting pathways in M1-Mɸ vs.M2-Mɸs.

lP

re

-p

ro

of

A. STRING network of proteins detected by quantitative proteomics in glycolysis pathway. Red color:
proteins are upregulated in M2-MФ; blue color: proteins are upregulated in M1-MФ. LOG2 (Fold
changes) of protein expressions (M2-MФ/ M1-MФ) are represented by the color key on the
bottom.
B. STRING network of proteins detected by quantitative proteomics in mitochondria respiratory
chains.
C. STRING network of proteins detected by quantitative proteomics in TCA cycle, pyruvate, and
aspartate/glutamate pathways.
D. Concentrations of asparagine, aspartic acid, glutamine, glutamic acid, acetylated aspartic acid,
acetylated glutamic acid, acetylated ornithine measured by LC/MS.
E. Heatmap of D.

na

Figure 7. Glucose tracing into key metabolites and histone acetylation
C3-enrichment of pyruvate and lactate and 13C2-enrichment of succinate from 13C6-glucose
metabolism.
B. Percentage of 13C2-acetyl enrichment of histone H3K18/K23 after MФs incubated with 13C6glucose for 48 h under normoxic and hypoxic conditions.
C. Diagram of 13C enrichment on glycolic and the TCA cycle metabolites and histone acetylation
derived from 13C6-glucose in M1-Mɸ.
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SUPPLEMENTAL FIGURES
Figure S1. Histone acetylation and methylation in M0-, M1-, and M2-MФs quantified by parallel-reactionmonitoring (PRM).
Figure S2. Concentrations of TCA cycle metabolites and N-acetyl-aspartate, -glutamate, and -ornithine
measured by LC-MS/MS.
Figure S3. MS/MS spectrum of N-alpha-acetyl-ornithine dansylated derivative.
Figure S4: Measurement of methyl and acetyl transfer from metabolites to histones.
Rate of transferring of 13C6-glucose to histones: intensity of peak at m/z 128.0981 (the immonium ion
of 13C2-acetylated lysine) over intensity of peak at m/z 126.0914 (the immonium ion of acetylated
lysine). Shown is a selective MS/MS spectrum of K9me1K14ac.
Figure S5. Altered one-carbon metabolism and histone methylation in M1- and M2-Mɸs.
20

A. A network built up from one carbon metabolism (folate cycle and methionine cycle) proteins
quantified by proteomics. Red color: Upregulated in M2-MФ; Blue color: upregulated in M1-MФ.
Color key is the same for B.
B. Heat map of the relative expression (M2/M1) of the networked proteins.
C. The concentration ratio of methionine (Met) over homocysteine (Hcy) in M0-, M1-, and M2-MФs.
D. The concentration ratio of S-adenosyl-L-methionine (SAM) over S-adenosyl-homocysteine (SAH)
in M0-, M1-, and M2-MФs.
E. Isotope tracing methyl transfer from 3,3,2-2H-serine to methionine (Met) and histone K9 mono(H3K9me1) and tri-methylation (H3K9me3).
F. A scheme showing the isotope 2H transferring from serine to histones through the one-carbon
pathway that is inhibited by NO.
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Figure S6. Fatty acid metabolism and oxidation.
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A. Networks built upon proteins quantified by proteomics in metabolic pathways of fatty acid
oxidation and elongation, as well as production and detoxification of oxidative species. Red color:
upregulated in M2-MФs. Blue color: upregulated in M1-MФs.
B. Concentrations (nmol/mg protein) of fatty acids and oxidized products in M0-, M1-, and M2-MФs.
4-HNE: 4-hydroxynonenal; AAAS: aminoadipic acid semialdehyde; AKBA: amino-ketobutyric acid.
C. Heat map showing the changes of the concentrations of fatty acids and oxidized products in B.
D. Networks built upon proteins quantified by proteomics in metabolic pathways of fatty acid
oxidation and elongation, as well as production and detoxification of oxidative species. Red color:
upregulated in M1-MФs. Blue color: upregulated in M0-MФs.
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